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Acetylene, thin films on silicone, LDI-FT-MS, 411
Acylglycines, urinary, analysis by UPLC-QLTC-MS, 2105
Adrenal glands, rat ovaries and, DBDE localization by TOF-
SIMS, 1836
Affinity mass spectroscopy
HIV gp120 epitopes mapped by MS, 1687
IMALDI MS assay for diagnosis of hypertension, 1680
phosphopeptide enrichment by MOAC resins, MS/MS, 1649
protein-ligand interactions, quantification by SAW-ESI-MS,
1643
proteins and peptides, affinity determination using HDX, 1660
serum protein samples in preeclampsia, multifactoral analysis
of affinity-MS data, 1699
targeted data acquisition for improved quantification, pro-
teomics, MS, 1668
Agarans, carrageenans and, sulfated oligosaccharide isomers,
ESI-MS, 1404
Air
atmosphere samples, expansion intervacuum in trapping par-
ticulate ions, 242
trace analyses, handheld mass spectrometer, APCI, 132
L-Alanine, sarcosine and, separation from urine, ESI and IMS-
(DMA)-MS, 1129
Aldehydes, PFBHA-derivatized, detection limits of EI- and
ECNI-MS, 592
Amino acids
distribution in SILAC experiments, QTIPS, 1417
effect of cysteine or arginine on peptide copper binding,
MALDI-TOF-MS, 522
influence of side chains on opening of cyclic bs ions, 1028
L-alanine and sarcosine separation from urine, ESI and IMS-
(DMA)-MS, 1129
peptide hydrogen transfer affected by charge state and com-
position of, ECD, 1979
reactions of aromatic ,  biradical with gas phase, 1737
5-Aminosalicycilic acid matrix, peptides, decay and fragmenta-
tion characteristics using, MALDI-ISD-MS, 979
Amyloid  peptides, interaction with anti-amyloid agents, ESI-
MS, 1506
Amyloids, investigating assembly pathways by ESI MS, 1087
Analytes
ionization of, regimen transition in electromechanical fluid
atomization and, MS, 1900
low-molecular weight, binary matrix for visible-MALDI, 294
Androgens, analysis of SARMs by GC-microchip APPI-MS, 310
Anion exchange chromatography, enrichment of sulfated gly-
cans by, prior to MS, 348
Anions
cations and, in siRNA, IRMPD, 580
metal, alkali metal oxalates, from CID, 1944
protoporphorin-IX triplet-triplet absorption by, electrostatic
ion storage ring, 1884
Antigen/antibody interactions, proteins and peptides, affinity
determination using HDX, 1660
AP-11, protein composition analyzed using MALDI LTQ Orbi-
trap, 34
APPI-MS. see Atmospheric pressure photoionization mass spec-
trometry
Arabidopsis thaliana, neutral cuticular lipids from, MALDI imag-
ing in insects and plants, 220
Arginine
effect on macrocyclic b ion formation, protonated peptides,
1322
methylation of lysine and, ETD-MS, 88
[ArNi(PPh3)N] , gas-phase cyclometalations, ESI-MS/MS, 1265
ASAP. see Atmospheric solids analysis probes
Aspartic residues, isoaspartic and differentiation, ETD, 1012
Asymmetric charge partitioning, DNA duplex dissociation and,
1144
Atmosphere samples, expansion intervacuum in trapping partic-
ulate ions, 242
Atmospheric pressure chemical ionization
effect-directed analysis of mutagenic compounds, HPLC/
APCI-FTICR-MS, 1016
handheld mass spectrometer, trace air analyses, 132
Atmospheric pressure matrix-assisted laser dissociation/ioniza-
tion mass spectrometry, B. thuringiensis spores, proteom-
ics approach to species-level identification, 993
Atmospheric pressure photoionization-ion mobility spectrometry-
mass spectrometry, separation of different ion structures
in, 1565
Atmospheric pressure photoionization mass spectrometry
gas phase Meerwein reaction, epoxides, 1802
GC-microchip, analysis of SARMs by, 310
Atmospheric solids analysis probes, sample introduction using,
LSI-MS, 1889
ATP binding sites, protein kinases, top-down MS, 899
b ions
analysis by H/D exchange kinetics during FT-ICR-MS, 358
effect of arginine on macrocyclic formation of, protonated
peptides, 1322
effect of His residues on cyclization of, peptides, 1352
macrocyclic, peptide sequence scrambling via, MS/MS, 2085
bs ions, cyclic, influence of AA side chains on opening, 1028
Bacillus thuringiensis, spores, proteomics approach to species-
level identification, AP-MALDI-MS, 993
Bacteriorhodopsin, site-directed mutagenesis and oxidative la-
beling, MS, 1947
Benzene, handheld mass spectrometer, trace air analyses, APCI,
132
Benzene-to-phenol conversion, by FeO, intermediates in,
IRMPD, 750
Benzylpyridinium “thermometer” ions, fragmentation of, ESI-
MS, 172
Beverages, cocaine detection in, using nanoEESI-MS, 290
Bioimaging, cerebral, in murine Parkinson’s disease model, LA-
ICP-MS, 161
Biomolecules
AC-ESI for MS, 1852
analysis by UASI MS, 1547
charged, protein interaction with, ESI-MS, 472
fluorescence probe of conformations, ITMS, 707
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Biopharmaceuticals, conformation and dynamics using MS, 323
Biosensors, protein-ligand interaction quantification by SAW-
ESI-MS, 1643
Book reviews
Differential Ion Mobility Spectrometry: Nonlinear Ion Transport
and Fundamentals of FAIMS, R4 (Apr)
Mass Spectrometry Analysis for Protein-Protein Interactions and
Dynamics, R2 (Mar)
Mass Spectrometry Instrumentation, Interpretation, and Applica-
tions, R1 (Jan)
Mass Spectrometry of Nucleosides and Nucleic Acids, R1 (Dec)
Report of the 2009 ASMS Fall Workshop: Bioinformatics for Pro-
tein Identification, R3 (Apr)
Review of the 22nd Sanibel Conference on Mass Spectrometry:
From Structural Biology to Drug Discovery: New Roles for
Mass Spectrometry of Nucleic Acids, R1 (Jul)
Boric acid, quantitative analysis by GC-MS, 482
Brain
human, cocaine, MALDI-MS analysis, 564
tissue sections, glycosphingolipids, use of gold nanoparticles
and, 1940
Buffer loading, effect for ESI-MS, noncovalent protein com-
plexes, 1045
c1 ions, formation in CID of peptides, 1814
Calibration function, space charge effect, Orbitrap FT-MS, 1846
Calibration standards, sulfur, for LDI-MS, 112
Calmodulin, macrophage, top-down LC-FTICR-MS, 930
Calorimetry
measurement of internal energy deposition in ion activation
using nanocalorimetry, 615
peptide dissociation energies and entropies, ion nanocalorim-
etry and CIA, 1133
Captopril, urine, quantification using SALVI-MS, 864
Carbamino groups, formation of, proteins and peptides, ESI-MS,
1500
Carbohydrates
EDTA in analysis of, ESI-MS, 1526
sugar isomers, analysis using the kinetic method, 60
Carbonyl functionality, hydroxyl functionality and, in protein-
ated bifunctional analytes prior to FTICR-MS, 773
Cardiolipins, structural analysis by ESI multiple stage LIT-MS,
1863
Carrageenans, agarans and, sulfated oligosaccharide isomers,
ESI-MS, 1404
Cations
-radical, fragmentation of arginine-containing peptides, CID,
511
anions and, in siRNA, IRMPD, 580
radical, gas-phase unimolecular chemistry of, cysteine-
containing peptides, 1296
Cavitands, phosphonate, hydrogen bonding in, 440
CD-ECI. see Corona discharge induced electrochemical ioniza-
tion
Cesium iodide, cluster ion generation for mass calibration,
MALDI-MS, 1223
Charge ratio, determines fragment efficiency, MS/MS of pep-
tides, 1857
Charge remote fragmentation, occurence in EDC and ETD, 646
Charge separation, in droplet-based ion sources, electrohydro-
dynamics, 501
Charge states, peptide hydrogen transfer affected by AA com-
position and, ECD, 1979
CID. see Collision-induced dissociation
Cisplatin, N-terminal platination of ubiquitin by, ion mobility
MS, 1097
Cluster ions, CsI, generation for mass calibration, MALDI-MS,
1223
Cluster secondary ion intensities, relationships between, 370
Cocaine
detection in beverages using nanoEESI-MS, 290
human brain tissue, MALDI-MS analysis, 564
Collision-assisted dissociation mass spectrometry. see Collision-
induced dissociation mass spectrometry
Collision-induced dissociation mass spectrometry
- and -acyl naphthalenes, assignment of constitutional iso-
mers using, 2041
alkali metal oxalates, metal ions from, 1944
arginine-containing peptides, fragmentation of -radical cat-
ions, 511
axial and high-pressure, using DAPI, ion trap mass spectrom-
eter, 209
deproteinated RNA, base loss and internal fragmentation, 278
HMGA1a modifications, combined CID- and ETD-MS, 950
ion trap, dissociation of locked nucleic acids, 144
peptides, c1 ion formation in, 1814
polylactide oligomers, 1159
prevalent fragmentation pathways, proteins, FT-ICR-MS, 949
protein kinase ATP binding sites, top-down MS, 899
Rice-Ramsperger-Kassel-Sarcus modeling, in MS/MS, 425
RNA sequencing by EDD and, top-down MS, 918
UO4- formed during, 1789
Collision-induced dissociation tandem mass spectrometry
benzyl-aminated peptides, gas-phase fragmentation character-
istics, 1624
lithiated olytetrahydrofuran, fragmentation properties, 1753
PEGylation sites for peptides and proteins identified using
ISF and, 810
surface mapping of proteins, 1339
Copper, binding by peptides, effect of cysteine or arginine on,
MALDI-TOF-MS, 522
Corona discharge induced electrochemical ionization, peptide
fragmentation by, 2051
Cuticle, neutral lipids from, MALDI imaging in insects and
plants, 220
Cyanuric acid, melamine and, gas-phase acid-base properties of,
1720
-Cyclodextrans, EDTA in ESI MS analysis, 1526
Cyclometalations, gas phase, [ArNi(PPh3)N] , ESI-MS/MS, 1265
Cystatins, human salivary, mass tag assignment, top-down FT-
ICR-MS, 908
Cytochrome c, ion/ion proton transfer reactions and conforma-
tion, 1208
DAPI. see Discontinuous atmospheric pressure interface
Data analysis
data format for mass spectrometry, proteomics, 1784
data reduction, automated feature identification, IMS, 1969
effect-directed analysis of mutagenic compounds, HPLC/
APCI-FTICR-MS, 1016
effects of data acquisition and, IRPD, 800
H/D exchange, automated data reduction, FT-ICR-MS, 550
mass measurement terminology and treatment of data, 1821
multifactoral analysis, serum protein samples in preeclampsia,
affinity-MS data, 1699
Data-dependent neutral gain MS3, N-oxide identification in drug
metabolites, 559
Databases
effect-directed analysis of mutagenic compounds, HPLC/
APCI-FTICR-MS, 1016
MAZIE enhances searching of MS/MS spectra, 80
DBDE. see Deca-bromo-diphenyl-ether residues
DCIM. see Drift cell ion mobility mass spectrometry
Deca-bromo-diphenyl-ether residues, localization by TOF-SIMS,
rat ovaries and adrenal glands, 1836
Deoxyribonucleosides, gas phase acidities of, 136
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DESI. see Desorption electrospray ionization
Design of Experiments, mixing ratios and MMD using, poly-
mers, MALDI-TOF-MS, 1870
Desorption electrospray ionization
enhanced ion signals via surfactant sprays, 1423
saturated hydrocarbon analysis by discharge-induced oxida-
tion in, 261
use of non-aqueous spray solvents in, 572
Desorption electrospray ionization mass spectrometry
human lens lipids, imaging by, 2095
imaging of rat spinal cord lipids, 1177
protein conformation in solution, 1730
Desorption ionization by charge exchange, sample analysis un-
der ambient conditions, 1554
Deuterium labeling, identification dinucleotide fragmentation
channels using, MS/MS, 23
Differential mobility analysis
ion-pair evaporation from ionic liquid clusters, 1382
L-alanine and sarcosine separation from urine, ESI and IMS-
(DMA)-MS, 1129
Differential mobility spectrometry, miniature mass spectrome-
ters, evaluation of, 1477
Digital asymmetric wave form isolation, in digital linear ion
trap, 1530
Digital linear ion trap, digital asymmetric wave form isolation
in, 1530
Dimethyl isotope labeling, peptide sequencing using, ESI-MS,
1957
Dinucleotides, identification of fragmentation channels using
deuterium labeling, MS/MS, 23
Dioxin, analysis by GC-FTICR MS, 1918
Direct analysis in real time mass spectrometry, nucleosides and
nucleotides, 1371
Direct analysis in real time time-of-flight mass spectrometry
internal energy deposition comparison in ESI-TOF-MS and,
855
optimization of, metabolomic fingerprinting, serum, 68
Discontinuous atmospheric pressure interface, axial and high-
pressure resonance CID using, ion trap-MS, 209
Dissociation energies, entropies and, peptides, ion nanocalorim-
etry and CIA, 1133
Dissociation kinetics, enkephalin and leucine, time resolved
photodissociation MALDI-TOF-MS/MS, 1151
Disulfide bonds, microwave-assisted acid and base hydrolysis of
proteins, sequence analysis by MS, 1596
DNA
duplex dissociation and asymmetric charge partitioning, 1144
thrombin-binding aptamer, alkali metal ion binding, 1245
DOE. see Design of Experiments
Drift cell ion mobility mass spectrometry, prion protein ana-
lyzed by T-wave IM-MS and, 845
Drosophila melanogaster, neutral cuticular lipids from, MALDI
imaging in insects and plants, 220
ECD-MS. see Electron capture dissociation mass spectrometry
Electospray ionization tandem mass spectrometry
microwave-assisted acid hydrolysis of proteins, analysis by
LC-ESI-MS/MS, 1573
quantification of isobaric phosphopeptides, IRS-1, HPLC-ESI-
MS/MS, 1490
thymidylate synthase inhibitor analogues, rearrangement in,
403
Electrohydrodynamics, charge separation in droplet-based ion
sources, 501
Electromechanical fluid atomization, analyte ionization and, reg-
imen transition in, MS, 1900
Electron capture dissociation
peptide hydrogen transfer affected by charge state and AA
composition, 1979
peptide: oligonucleotide heteroconjugates, sequence analysis,
ECD and ETD, 1387
Electron capture dissociation Fourier transform ion cyclotron
resonance mass spectrometry, top-down protein sequenc-
ing, SEI-FTICR-MS and, 1966
Electron capture dissociation mass spectrometry
charge remote fragmentation in ETD and, 646
of metallo-supramolecular complexes, 300
peptides, structural motifs suppressing ion fragmentation,
1235
protein kinase ATP binding sites, top-down MS, 899
tyrosine nitrated peptides, 268
Electron capture negative ionization mass spectrometry, PF-
BHA-derivatized aldehydes, detection limits of EI- and
ECNI-MS, 592
Electron detachment dissociation mass spectrometry
peptide dissociation of polyanions by EDD and EPD, 670
RNA sequencing by CAD and, top-down MS, 918
Electron-induced dissociation mass spectrometry, structural
analysis of trinuclear oxo-centered carboxylate-bridged
ion complexes, EID FT-ICR-MS, 1398
Electron ionization mass spectrometry, PFBHA-derivatized alde-
hydes, detection limits of EI- and ECNI-MS, 592
Electron photodetachment dissociation mass spectrometry, pep-
tide dissociation of polyanions by EDD and EPD, 670
Electron transfer dissociation mass spectrometry
analysis of arginine and lysine methylation, 88
charge remote fragmentation in ECD and, 646
differentiation of aspartic and isoaspartic residues, 1012
high-energy, sequence analysis of posttranslational peptides,
1482
HMGA1a modifications, combined CID- and ETD-MS, 950
peptide:oligonucleotide heteroconjugates, sequence analysis,
ECD and ETD, 1387
Electronic spectra, C6H
 and C6H3 in gas phase, 694
Electrospray ionization Fourier transform ion cyclotron reso-
nance mass spectrometry, top-down protein sequencing,
ECD-FTICR-MS and, 1966
Electrospray ionization linear ion trap mass spectrometry
multiple stage, structural analysis of cardiolipins by, 1863
triacylglycerol analysis by, 657
Electrospray ionization mass spectrometry
agarans and carrageenans, sulfated oligosaccharide isomers,
1404
alternating current, biomolecules, 1852
A peptide interaction with anti-amyloid agents, 1506
buffer loading effect for, noncovalent protein complexes, 1045
comparison with LSI IMS MS, 1260
EDTA in carbohydrate analysis, 1526
evolution of solvent polarity in plume, 378
fragmentation of benzylpyridinium “thermometer” ions, 172
fusaric acid as derivatizing reagent for hydroxy steroids quan-
tification, LC-ESI-MS/MS, 249
investigating amyloid assembly pathways by, 1087
L-alanine and sarcosine separation from urine, ESI- and IMS-
(DMA)-MS, 1129
metabolomics and construction of metabolite atlases, 1471
myoglobins, supercharging reagents and conformation, 1762
N-terminal tagging of peptides for denovo sequencing, ESI-
MS/MS and MALDI-MS/MS, 104
nanoextractive, cocaine detection in beverages, 290
-stacking interactions, mixed-ligand sandwich complexes,
545
peptide sequencing using dimethyl isotope labeling, 1957
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phenanthroline-functionalized PEG-iron(2) complexes, ligand
size distribution, 1561
probing hydrophobic effect by MALDI-MS and, noncovalent
complexes, 286
protein interaction with charged biomolecules, 472
proteins and peptides, carabamino group formation, 1500
quantification of protein-ligand interactions, 1893
quantification of thyroid hormones T3 and rT3 by single ratio
kinetic method, 14
reagents for supercharging of proteins and protein complexes,
127
segmented flow, enzyme inhibitor screening using, 1107
Electrospray ionization tandem mass spectrometry,
[ArNi(PPh3)N] gas-phase cyclometalations, 1265
Electrospray ionization time-of-flight mass spectrometry, inter-
nal energy deposition comparison in DART and, 855
Electrostatic ion storage ring, protoporphorin-IX triplet-triplet
absorption by anions, 1884
Embryonic stem cells, human, SILAC labeled, quantitative top-
down proteomics, 879
Enkephalin, leucine and, dissociation kinetics, time resolved
photodissociation MALDI-TOF-MS/MS, 1151
Enzyme inhibitors, screening using segmented flow ESI-MS,
1107
Enzymes, tyrosylprotein sulfotransferase-2, catalytic mechanism
analyzed by MS, 1633
Epoxides, gas-phase Meerwein reaction from APPI, 1802
ETD-MS. see Electron transfer dissociation mass spectrometry
Ethylbenzene, handheld mass spectrometer, trace air analyses,
APCI, 132
Ethylenediaminetetraacetic acid, in carbohydrate analysis, ESI
MS, 1526
FAIMS. see High-field asymmetric wave form ion mobility spec-
trometry
FAPA. see Flowing atmospheric pressure afterglow
Fatty acids, distribution in mouse retinal sections, IMS with sil-
ver nanoparticles, 1446
Flowing atmospheric pressure afterglow, positive and negative
ions from, detected using MHMS, 97
Fluorescence probes, of peptide conformations, ITMS, 707
Fourier transform ion cyclotron resonance mass spectrometry
b fragment ion analysis by H/D exchange kinetics during, 358
effect-directed analysis of mutagenic compounds, HPLC/
APCI-FTICR-MS, 1016
effects of higher magnetic fields, peptides, 1218
GC, dioxin analysis by, 1918
H/D exchange, automated data reduction, 550
high resolution top-down, peptide P-C in human saliva ana-
lyzed by, 868
peptide sequencing on single resin beads, MALDI-FTICR-MS/
MS, 215
PIC comparison with frequency shifts between ions in, 203
proteins, prevalent fragmentation pathways, 949
quantification of two species in plasma regimen, 1712
top-down, human salivary cystatins, mass tag assignment, 908
top-down LC, macrophage calmodulin, 930
Fragmentation
of arginine-containing peptides, CID, 511
benzylpyridinium “thermometer” ions, ESI-MS, 172
characteristics, 5-Aminosalicycilic acid matrix peptides, decay
and, MALDI-ISD-MS, 979
charge remote, occurence in EDC and ETD, 646
conformation-specific photofragmentation, proline-containing
peptide ions, 1455
gas-phase, benzyl-aminated peptides, CID-MS/MS, 1624
Lithiated olytetrahydrofuran, CID-MS/MS, 1753
peptide, by corona discharge induced electrochemical ioniza-
tion, 2051
peptide, characteristics using 5-ASA matrix, MALDI-ISD-MS,
979
peptide, in-source decay and, MALDI-TOF-MS, 1906
Photofragmentation, photoinduced dissociation of heparin-
derived oligosaccharides, 2077
prevalent pathways, proteins, FT-ICR-MS, 949
protein, Lys-N proteolysis and N-terminal guanidination for,
1050
protein, N-terminal guanidation and Lys-N proteolysis, 1050
protonated peptides, mobile proton hypothesis, 1275
Fragmentation channels, dinucleotides, identification of using
deuterium labeling, MS/MS, 23
Fructans, EDTA in ESI MS analysis, 1526
Fructose, isomers of, analysis using the kinetic method, 60
FTICR-MS. see Fourier transform ion cyclotron resonance mass
spectrometry
Fullerene, anion hydrogenation then IRMPA dehydrogenation,
117
Fusaric acid, derivatizing reagent for hydroxy steroid quantifica-
tion, LC-ESI-MS/MS, 249
Galactose, isomers of, analysis using the kinetic method, 60
Gas chromatography mass spectrometry
dioxin analysis by GC-FTICR-MS, 1918
quantitative analysis of boric acid, 482
Gas phase
acidities of deoxyribonucleosides, 136
[ArNi(PPh3)N]
*, cyclometalations, ESI-MS/MS, 1265
electronic spectra of C6H
 and C6H3 in, 694
infrared spectroscopy, manganese ions, 758
Meerwein reaction, epoxides, APPI-MS, 1802
reactions of aromatic ,  biradical with, 1737
Gaseous tungstate ions, detection of, LDI MS, comment and re-
ply, 1466
Genomics, MS analysis of nucleic acids in post-genomics age, 1
Glucose, isomers of, analysis using the kinetic method, 60
Glutamic acid, N-terminal, effect on fragmentation of glutamine
and, 1169
Glutamine, effect of N-terminal glutamic acid and on fragmen-
tation, 1169
Glycans, sulfated, enrichment by anion exchange chromatogra-
phy prior to MS, 348
Glycosphingolipids, brain tissue sections, use of gold nanopar-
ticles and IMS, 1940
Gold particles, brain tissue sections, glycosphingolipids in, use
of IMS and, 1940
gp120, epitopes mapped by MS, 1687
Guanidation, N-terminal, Lys-N proteolysis and, for protein
fragmentation, 1050
Hand held spectrometers, miniature mass spectrometers/DMS
systems, evaluation of, 1477
Heparin oligosaccharides, UV-MALDI-TOF-MS analysis, 178
Heteroconjugates, peptide:oligonucleotide, sequence analysis,
ECD and ETD, 1387
High-field asymmetric wave form ion mobility spectrometry
high-voltage asymmetric wave form generator for, 1118
ion peak narrowing by AC voltage application, 47
High mobility group protein A1a, modifications of, combined
CID- and ETD-MS, 950
High performance liquid chromatography
effect-directed analysis of mutagenic compounds, HPLC/
APCI-FTICR-MS, 1016
quantification of isobaric phosphopeptides, IRS-1, HPLC-ESI-
MS/MS, 1490
His residues, effect on b ion cyclization, peptides, 1352
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HIV, gp120 epitopes mapped by MS, 1687
Hormone receptors, nuclear, complex with nucleic acids,
MALDI-MS, 635
Human embryonic stem cells, SILAC labeled, quantitative top-
down proteomics, 879
Hydrocarbons, saturated, analysis by discharge-induced oxida-
tion in DESI, 261
Hydrogen bonding, in phosphonate cavitands, 440
Hydrogen/deuterium exchange
automated data reduction, FT-ICR-MS, 550
isomeric ions identified by QCID-HDX-IRMPD, 1329
kinetics of, b fragment ion analysis by, during FT-ICR-MS,
358
leu-enkephalin, oxazolone versus macrocyclic structures, IR-
MPD and, 1313
MS coupled, analysis of acidic proteases by, 76
proteins and peptides, affinity determination using, 1660
Hydrogenation cycle, Fullerene anion hydrogenation then
IRMPA dehydrogenation, 117
Hydrophobic effects, noncovalent complex, probing by ESI- and
MALDI-MS, 286
Hydroxy steroids, fusaric acid as derivatizing reagent for quan-
tification of, LC-ESI-MS/MS, 249
Hydroxyl functionality, carbonyl functionality and, in protein-
ated bifunctional analytes prior to FTICR-MS, 773
Hyla arborea (tree frog), N-terminal tagging of peptides for de-
novo sequencing, ESI-MS/MS and MALDI-MS/MS, 104
Hypertension, iMALDI MS assay for diagnosis of, 1680
Imaging mass spectrometry
data reduction, automated feature identification, 1969
glycosphingolipids, brain tissue sections, use of gold nanopar-
ticles and, 1940
high resolution imaging using a medipix pixelated detector,
2023
with silver nanoparticles, fatty acid distribution in mouse ret-
ina sections, 1446
In-source decay, PSD and, peptides, MALDI-TOF-MS, 1876
In-source fragmentation
PEGylation sites for peptides and proteins identified using
CID-MS/MS and, 810
peptides, MALDI-TOF-MS, 1906
Inborn errors of metabolism, urinary acylglycine analysis by
UPLC-QLTC-MS, 2105
Information management, MAZIE enhances database searching
of MS/MS spectra, 80
Infrared multiphoton activation, Fullerene anion hydrogenation
then dehydrogenation, 117
Infrared multiphoton dissociation
anions and cations in siRNA, 580
intermediates in benzene-to-phenol conversion by FeO, 750
isomeric ions identified by QCID-HDX-IRMPD, 1329
structure of deproteinated tri-alanine and a3 fragment anion,
694
structure of sodiated octaglycine, 728
uranyl carboxylates, variable denticity in coordination com-
plexes, 719
Infrared multiphoton dissociation spectroscopy, leu-enkephalin,
oxazolone versus macrocyclic structures, IR-MPD and
HDX, 1313
Infrared photodissociation spectroscopy
effects of data acquisition and analysis methods, 800
gas phase, structure of manganese ions, 758
structure of manganese carbonyl cations, 739
Insects, neutral cuticular lipids from, MALDI imaging in plants
and, 220
Insulin receptor substrate-1, quantification of isobaric phos-
phopeptides, HPLC-ESI-MS/MS, 1490
Internal energy deposition, comparison in DART and ESI-TOF-
MS, 855
Ion cyclotron resonance mass spectrometer traps, electrically
compensated, tuning method for, 451
Ion mobility mass spectrometry
L-alanine and sarcosine separation from urine, ESI and IMS-
(DMA)-MS, 1129
N-terminal platination of ubiquitin by cisplatin, 1097
Ion-neutral complexes, from dissociated proteination, 626
Ion-pair evaporation, from ionic liquid clusters, DMA, 1382
Ion sources, droplet-based, charge separation in, electrohydro-
dynamics, 501
Ion spectroscopy
electronic spectra of C6H
 and C6H3 in gas phase, 694
fluorescence probe of conformations, ITMS, 707
gas phase IRPD, structure of manganese ions, 758
intermediates in benzene-to-phenol conversion by FeO,
IRMPD, 750
IRMPD, structure of deproteinated tri-alanine and a3 fragment
anion, 694
review, 681
structure of manganese carbonyl cations, IRPD, 739
structure of sodiated octaglycine, IRMPD, 728
uranyl carboxylates, variable denticity in coordination com-
plexes, IRMPD, 719
Ion storage ring, electrostatic, protoporphorin-IX triplet-triplet
absorption by anions, 1884
Ion trap collision induced dissociation mass spectrometry, top-
down, of tRNA, 890
Ion trap mass spectrometer
axial and high-pressure resonance CID using DAPI, 209
fluorescence probe of biomolecule conformations, 707
nonlinear, characteristics of stability and boundary and fre-
quency, 1588
Ionic liquid clusters, ion-pair evaporation from, DMA, 1382
Ions, from FAPA detected using MHMS, 97
IRMPA. see Infrared multiphoton activation
Iron complexes, phenanthroline-functionalized PEG-iron(2) com-
plexes, ligand size distribution, ESI-MS, 1561
Iron oxides, speciation using high irradiance by LI-TOF-MS,
1227
IRS-1. see Insulin receptor substrate-1
ISD. see In-source decay
ISF. see In-source fragmentation
Islands of stability, mass analysis of linear quadrupoles, 393
Isoaspartic residues, aspartic residues and differentiation, ETD,
1012
Isoelectric focusing, peptide and protein identification by iso-
electric point-based fractionation, LC and MS, 1612
Isoelectric point-based fractionation, identification of proteins
and peptides by , LC and MS, 1612
Isotope dimethyl labeling, proteins, mapping of N-terminus
phosphorylation sites, 460
Isotope ratios, metabolites, selective signal detection using, LC-
MS, 232
Kinetic methods
analysis of isomeric sugars using, 60
single-ratio, quantification of thyroid hormones T3 and rT3 by,
ESI-MS, 14
Kinomes, targeted data acquisition for improved quantification,
MS, 1668
LA-ICP-MS. see Laser ablation inductively coupled plasma mass
spectrometry
Laser ablation inductively coupled plasma mass spectrometry,
cerebral bioimaging in murine Parkinson’s disease model,
161
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Laser desorption ionization mass spectrometry
acetylene thin films on silicone, LDI-FT-MS, 411
calibration standards for sulfur, 112
detection of gaseous tungstate ions, comment and reply, 1466
Laser-induced ionization/dissociation tandem mass spectrome-
try, femtosecond, protonated phosphopeptide ions char-
acterization by, 2031
Laser ionization time-of-flight mass spectrometry, iron oxides,
speciation using high irradiance by, 1227
Laser spray ionization ion mobility spectrometry mass spec-
trometry, comparison with ESI-MS, 1260
Laser spray ionization mass spectrometry, sample introduction
using ASAP, 1889
LDI-MS. see Laser desorption ionization mass spectrometry
Lens, human eye, lipid imaging by DESI-MS, 2095
Leu-enkephalin, oxazolone versus macrocyclic structures, IR-
MPD and HDX, 1313
Leucine, enkephalin and, dissociation kinetics, time resolved
photodissociation MALDI-TOF-MS/MS, 1151
Linear ion traps
digital, digital asymmetric wave form isolation in, 1530
fabricated using rapid manufacturing technology, 317
tandem, ozone-induced lipid dissociation, 1989
Linear quadrupoles, mass analysis with islands of stability, 393
Lipid A, Yersinia pestis, phosphorylation configuration, MS/MS,
785
Lipids
human lens, imaging by DESI-MS, 2095
neutral cuticular, MALDI imaging in insects and plants, 220
ozone-induced dissociation, tandem ion linear trap, 1989
rat spinal cord, DESI MS imaging, 1177
Liquid chromatography mass spectrometry
fusaric acid as derivatizing reagent for hydroxy steroids quan-
tification, LC-ESI-MS/MS, 249
metabolites, selective signal detection using isotope ratios, 232
microwave-assisted acid hydrolysis of proteins, analysis by
LC-ESI-MS/MS, 1573
protein and peptide identification by isoelectric point-based
fractionation, 1612
TCEP cleavage of cysteine-containing proteins, LC/MS/MS,
837
Locked nucleic acids, ion trap CID of, 144
Low-molecular weight analytes, binary matrix for visible-
MALDI, 294
LSI IMS MS. see Laser spray ionization ion mobility spectrome-
try mass spectrometry
LTQ Orbitrap mass spectrometry, resolution parameters for,
proteomics, 1606
Lysine, methylation of arginine and, ETD-MS, 88
Macrocyclic structures
effect of arginine on b ion formation, protonated peptides,
1322
oxazolone versus, leu-enkephalin, IR-MPD and HDX, 1313
Magnetic fields
effect of axial magnetic field on QMS, 2070
effects of, peptides, FT-ICR-MS, 1218
Maltoses, EDTA in ESI MS analysis, 1526
Manganese carbonyl cations, structure, IRPD spectroscopy, 739
Manganese ions, gas phase IRPD spectroscopy, 758
Mass and charge (z) inference engine, enhances database search-
ing of MS/MS spectra, 80
Mass calibration, CsI, cluster ion generation for, MALDI-MS,
1223
Mass measurement, terminology and treatment of data, 1821
Mass spectrometry. see also Specific technologies
conformation and dynamics of biopharmaceuticals using, 323
macromolecular structure of proteins, 487
structural biology-based, limitations, 971
top down, future of, 193
Matrices, binary, for visible-MALDI, LMW analytes, 294
Matrix-assisted laser desorption/ionization Fourier transform
ion cyclotron resonance mass spectrometry, peptide pro-
filing in serum, isotopic distribution for QC, MALDI-
TOF- and, 1515
Matrix-assisted laser desorption/ionization ion mobility mass
spectrometry, on-tissue protein identification and imag-
ing, 338
Matrix-assisted laser desorption/ionization ISD mass spectros-
copy, decay and fragmentation characteristics using
5-ASA matrix, 979
Matrix-assisted laser desorption/ionization mass spectrometry
characterization of unknown compounds in stainless steel
plates, 2000
chemical cross-linking and noncovalent interactions, MALDI-
MS, 1775
cocaine in human brain samples, 564
CsI cluster ion generation for mass calibration, 1223
enkephalin and leucine dissociation kinetics, time resolved
photodissociation MALDI-TOF-MS/MS, 1151
IMALDI-MS assay for diagnosis of hypertension, 1680
MW determination of poly(methyl methylacrylate) and poly-
(methyacrylic acid) copolymers, 1075
N-terminal tagging of peptides for denovo sequencing, ESI-
MS/MS and MALDI-MS/MS, 104
nuclear hormone receptor complexes with nucleic acids, 635
peptide sequencing on single resin beads, MALDI-FTICR-MS/
MS, 215
phosphorylation site-specific dissociation, phosphopeptides,
53
probing hydrophobic effect by ESI-MS and, noncovalent com-
plexes, 286
protein composition analyzed using MALDI-LTQ-Orbitrap, 34
tissue section proteins, imaging and profiling, 1922
visible, binary matrices for, LMW analytes, 294
Matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry
DHB-modified nanoparticles, matrix for analysis of small mol-
ecules, 1930
effect of cysteine or arginine on peptide copper binding, 522
ISD and PSD, peptides, 1876
ISD fragmentation, peptides, MALDI-TOF-MS, 1906
novel strategy for small molecule analysis, 154
peptide profiling in serum, isotopic distribution for QC,
MALDI-FTICR-MS and, 1515
polymers, mixing ratio and MMD using DOE, 1870
proteins containing thiol ester-linked sinapinic acid, MALDI-
TOF-TOF-MS, 819
UV, heparin oligosaccharides, 178
Mattauch-Herzog mass spectrograph, positive and negative ions
from FAPA detected using, 97
MAZIE. see Mass and charge (z) inference engine
Medipix pixelated detector, high resolution imaging using, IMS,
2023
Meerwein reaction, gas-phase, epoxides, from APPI, 1802
Melamine, cyanuric acid and, gas-phase acid-base properties of,
1720
Metabolite atlases, metabolomics and construction of, 1471
Metabolites
exhaled volatile, repeatability of SIFT-MS, 1070
N-oxide identification in drug metabolites, data-dependent
neutral gain MS3, 559
selective signal detection using isotope ratios, LC-MS, 232
Metabolomics
construction of metabolite atlases and, 1471
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serum, optimization of DART-TOF-MS, 68
urinary acylglycine analysis by UPLC-QLTC-MS, 2105
Metal oxide affinity chromatography resins, phosphopeptide
enrichment by, MS/MS, 1649
Metallo-supramolecular complexes, ECD-MS of, 300
Metals
anions, alkali metal oxalates, from CID, 1944
murine model of Parkinson’s disease, cerebral bioimaging us-
ing LA-ICP-MS, 161
Methyl radicals, polycyclic aromatic hydrocarbon growth and,
534
Methylene blue, nano-porous silicon layer adsorption of papain
and, TOF-SIMS, 254
MHMS. see Mattauch-Herzog mass spectrograph
Microwave-assisted acid hydrolysis
protein, analysis by LC-ESI-MS/MS, 1573
proteins, sequence analysis by MS, 1596
Miniature mass spectrometers, DMS, evaluation of, 1477
Mixing ratio, MMD and, using DOE, polymers, MALDI-TOF-
MS, 1870
MMD. see Molar mass distributions
MOAC. see Metal oxide affinity chromatography resins
Mobile proton hypothesis
cysteine-containing peptides, gas-phase unimolecular chemis-
try of radical cations, 1296
fragmentation of protonated peptides and, 1275
isomeric ions identified by QCID-HDX-IRMPD, 1329
leu-enkephalin, oxazolone versus macrocyclic structures, IR-
MPD and HDX, 1313
non-tryptic peptides, dissociations of z ions, 1279
peptides, effect of His residue on b ion cyclization, 1352
protonated peptides, arginine effect on macrocyclic b ion for-
mation, 1322
surface mapping of proteins, CID-MS/MS, 1339
Molar mass distributions, mixing ratios and, using DOE, poly-
mers, MALDI-TOF-MS, 1870
Molecular weight, poly(methyl methylacrylate) and poly
(methyacrylic acid) copolymers, MALDI, 1075
MudPIT. see Multidimensional protein identification technology
Multidimensional protein identification technology, proteins,
quantitation, spectral counting error statistics, 1534
Mutagenic compounds, effect-directed analysis, HPLC/APCI-
FTICR-MS, 1016
Myoglobins, supercharging reagents and conformation, ESI,
1762
N-oxides, identification in drug metabolites, data-dependent
neutral gain MS3, 559
Nanocalorimetry, measurement of internal energy deposition in
ion activation using, 615
Nanoextractive electrospray ionization mass spectrometry, co-
caine detection in beverages, 290
Nanoparticles, DHB-modified, matrix for analysis of small mole-
cules, MALDI-TOF-MS, 1930
Nanostructure-assisted laser desorption/ionization time-of-flight
mass spectrometry, organometallic compounds, 1256
Nanotomes, cluster bombardment after sample preparation for
imaging by SIMS, 833
Naphthalenes, - and -acyl, assignment of constitutional iso-
mers, CID-MS, 2041
Neobellieria bullata, neutral cuticular lipids from, MALDI imag-
ing in insects and plants, 220
Noncovalent complexes, probing hydrophobic effect by ESI- and
MALDI-MS, 286
Nonlinear ion trap mass spectrometry, characteristics of stability
and boundary and frequency, 1588
Nucleic acids
locked, ion trap CID of, 144
MS analysis in post-genomics age, 1
nuclear hormone receptor complexes with, MALDI-MS, 635
Nucleosides, nucleotides and, DART-MS analysis, 1371
Nucleotides, nucleosides and, DART-MS analysis, 1371
Nup84, protein composition analyzed using MALDI-LTQ Orbi-
trap, 34
Octaglycine, sodiated, structure of, IRMPD, 728
Oligonucleotides, peptide:oligonucleotide heteroconjugates, se-
quence analysis, ECD and ETD, 1387
Oligosaccharides
heparin, UV-MALDI-TOF-MS analysis, 178
heparin-derived, photoinduced dissociation of, 2077
sulfated isomers, agarans and carrageenans, ESI-MS, 1404
Orbitrap Fourier transform mass spectrometry, calibration func-
tion in space charge effect, 1846
Organic compounds, volatile, analyzed by femtosecond laser
MS, 1122
Organometallic compounds, analysis by NALDI-TOF-MS, 1256
Ovaries, rat adrenal glands and, DBDE localization by TOF-
SIMS, 1836
Oxalates, alkali metal, metal anions from CID, 1944
Oxazolone, macrocyclic structures versus, leu-enkephalin, IR-
MPD and HDX, 1313
Oxidative labeling, site-directed mutagenesis and, bacteriorho-
dopsin, MS, 1947
Ozone-induced dissociation, lipids, tandem linear ion trap, 1989
Papain, nano-porous silicon layer adsorption of methylene blue
and, TOF-SIMS, 254
Parkinson’s disease, murine model of, cerebral bioimaging using
LA-ICP-MS, 161
Particle-in-cell simulations
comparison with frequency shifts between ions in FTICR-MS,
203
quantification of two species in plasma regimen, FTICR-MS,
1712
Particulate ions, role of expansion intervacuum in trapping at-
mosphere sample, 242
PEGylation sites, for peptides and proteins identified using ISF
and CID-MS/MS, 810
Peptides
arginine-containing, fragmentation of -radical cations, CID,
511
aspartic and isoaspartic residue differentiation, ETD, 1012
benzyl-aminated, gas-phase fragmentation characteristics,
CID-MS/MS, 1624
c1 ion formation in CID of, 1814
carbonylated, 18O-labeling for proteomic analysis, MS, 1190
charge ratio determines fragment efficiency, MS/MS, 1857
charge remote fragmentation in EDC and ETD, 646
chemically cross-linked, TWIM-MS, 2062
cross-linked, enrichment by chemical ligation and MS, 1432
cysteine-containing, gas-phase unimolecular chemistry of radi-
cal cations, 1296
cysteine-polyglycine, gas-phase acidities, 603
decay and fragmentation characteristics using 5-ASA matrix,
MALDI-ISD-MS, 979
dissociation energies and entropies, ion nanocalorimetry and
CIA, 1133
dissociation of polyanions by EDD and EPD, 670
effect of cysteine or arginine on copper binding, MALDI-TOF-
MS, 522
effect of His residue on b ion cyclization, 1352
effects of higher magnetic fields, FT-ICR-MS, 1218
fluorescence probe of conformations, ITMS, 707
fragmentation by CD-ECI, 2051
H/C exchange kinetics during gas-phase sequencing, 358
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human saliva peptide P-C, analyzed by high resolution top-
down FT-MS, 868
hydrogen transfer affected by charge state and AA composi-
tion, ECD, 1979
ISD and PSD, MALDI-TOF-MS, 1876
ISD fragmentation, MALDI-TOF-MS, 1906
isomeric ions identified by QCID-HDX-IRMPD, 1329
N-terminal glutamic acid and glutamine effect on fragmenta-
tion, 1169
N-terminal tagging for denovo sequencing, ESI-MS/MS and
MALDI-MS/MS, 104
non-tryptic, dissociations of z ions, 1279
PEGylation sites identified using ISF and CID-MS/MS, 810
peptide:oligonucleotide heteroconjugates, sequence analysis,
ECD and ETD, 1387
posttranslational, sequence analysis of, HE-ETD, 1482
profiling in serum, isotopic distribution for QC, MALDI-TOF-
and MALDI-FTICR-MS, 1515
proline-containing ions, conformation-specific photofragmen-
tation, 1455
proteins and, carabamino group formation, ESI-MS, 1500
proteins and, identification by isoelectric point-based fraction-
ation, LC and MS, 1612
proteins and, SALDI MS, 1204
protonated, arginine effect on macrocyclic b ion formation,
1322
protonated, mobile proton hypothesis in fragmentation, 1275
reactions of aromatic ,  biradical with gas phase, 1737
sequence scrambling via macrocyclic b ions, MS/MS, 2085
sequencing on single resin beads, MALDI-FTICR-MS/MS, 215
sequencing using dimethyl isotope labeling, ESI-MS, 1957
structural motifs suppressing ion fragmentation, EC, 1235
tyrosine nitrated, ECD-MS, 268
Petroleum, in toluene, APCI analysis, 386
Pharmaceuticals, N-oxide identification in drug metabolites, da-
ta-dependent neutral gain MS3, 559
Phoenix spp., neutral cuticular lipids from, MALDI imaging in
insects and plants, 220
Phosphonate cavitands, hydrogen bonding in, 440
Phosphopeptides
enrichment by MOAC resins, MS/MS, 1649
isobaric, quantification of, IRS-1, HPLC-ESI-MS/MS, 1490
phosphorylation site-specific dissociation, 53
protonated ions, characterization by fs-LID-MS/MS, 2031
Phosphorylation
proteins, mapping N-terminus sites for, isotope dimethyl la-
beling, 460
site-specific dissociation, phosphopeptides, 53
Photofragmentation
conformation-specific, proline-containing peptide ions, 1455
photoinduced dissociation of heparin-derived oligosaccha-
rides, 2077
PIC simulations. see Particle-in-cell simulations
-Stacking interactions, mixed-ligand sandwich complexes, ESI-
MS, 545
Plants, neutral cuticular lipids from, MALDI imaging in insects
and, 220
Plasmepsin 2, analysis by H/D exchange coupled to MS, 76
Plasmepsin 4, analysis by H/D exchange coupled to MS, 76
Platination, ubiquitin N-terminal, by cisplatin, ion mobility MS,
1097
Poincare-Lighthill-Kuo method, characteristics of stability and
boundary and frequency of nonlinear ion trap mass spec-
trometry, 1588
Polyanions, peptide dissociation of, EDD and EPD, 670
Polycyclic aromatic hydrocarbons, methyl radicals and growth
of, 534
Polyethylene glycol-iron(2) complexes, phenanthroline-function-
alized, ligand size distribution, ESI-MS, 1561
Polylactide, oligomers, CID of, 1159
Polymers, mixing ratio and MMD using DOE, MALDI-TOF-MS,
1870
Poly(methyl methylacrylate), poly(methyacrylic acid), molecular
weight determination of copolymers, MALDI, 1075
Polytetrahydrofuran, lithiated, fragmentation properties, CID-
MS/MS, 1753
Portable mass spectrometry, handheld mass spectrometer, trace
air analyses, APCI, 132
Positive ion atmospheric pressure chemical ionization, analysis
of petroleum in toluene, 386
Post-source decay, ISD and, peptides, MALDI-TOF-MS, 1876
Preeclampsia, serum protein samples, multifactoral analysis of
affinity-MS data, 1699
Prion proteins, analysis by DCIM and T-wave IM-MS, 845
Proline, peptide ions containing, conformation-specific photo-
fragmentation, 1455
Proteases, acidic, analysis by H/D exchange coupled to MS, 76
Protein kinases, ATP binding sites, top-down MS, 899
Protein-ligand interactions
quantification by SAW-ESI-MS, 1643
quantification of, ESI-MS, 1893
Protein-protein interactions, chemical cross-linking and nonco-
valent interactions, MALDI-MS, 1775
Proteination, dissociated, ion-neutral complexes from, 626
Proteins
biotherapeutic, quantitation by targeted ion parking, 2011
chemical cross-linking and noncovalent interactions, MALDI-
MS, 1775
composition analyzed using MALDI-LTQ Orbitrap, 34
conformation in solution, DESI-MS, 1730
cysteine-containing, TCEP related cleavage, LC/MS/MS, 837
interaction with charged biomolecules, ESI-MS, 472
Lys-N proteolysis and N-terminal guanidination for fragmen-
tation, 1050
macromolecular structure, MS, 487
mapping N-terminus phosphorylation sites by isotope di-
methyl labeling, 460
microwave-assisted acid and base hydrolysis, sequence analy-
sis by MS, 1596
microwave-assisted acid hydrolysis, analysis by LC-ESI-MS/
MS, 1573
myoglobins, supercharging reagents and conformation, ESI,
1762
noncovalent complexes, buffer loading effect for ESI-MS, 1045
on-tissue identification and imaging of, MALDI-IMS, 338
oxidation of tryptophan residues, MS, 1114
PEGylation sites identified using ISF and CID-MS/MS, 810
peptides and, affinity determination using HDX, 1660
peptides and, carabamino group formation, ESI-MS, 1500
peptides and, identification by isoelectric point-based fraction-
ation, LC and MS, 1612
peptides and, SALDI-MS, 1204
prevalent fragmentation pathways, FT-ICR-MS, 949
quantitation, spectral counting error statistics, MudPIT, 1534
reagents for ESI-MS supercharging, 127
surface mapping, CID-MS/MS, 1339
thiol ester-linked sinapinic acid, MALDI-TOF-TOF-MS, 819
tissue sections, imaging and profiling, MALDI-MS, 1922
top-down sequencing, ESI- and ECD-FTICR-MS, 1966
Proteolysis, in situ MS-guided, x-ray structure determination,
1795
Proteomics
data format for mass spectrometry, 1784
high-throughput, MS cluster for, 1002
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18O-labeling of carbonylated peptides for, MS, 1190
resolution parameters for LTQ-Orbitrap MS, 1606
targeted data acquisition for improved quantification, MS,
1668
top-down, mass selectivity for, using SWIFT, 455
top-down, SILAC-labeled human embryonic stem cells, 879
Proton Transer Reactor Time-of-flight Mass Spectrometer, high
resolution, VOC formula confirmation by, 1037
Protoporphorin-IX, triplet-triplet absorption by anions, electro-
static ion storage ring, 1884
PSD. see Post-source decay
PTR-TOF. see Proton Transer Reactor Time-of-flight Mass Spec-
trometer
QTIPS. see Quantification by total identified peptides
Quadrupole collision-induced dissociation, isomeric ions identi-
fied by QCID-HDX-IRMPD, 1329
Quadrupole linear ion trap mass spectrometry, UPLC, urinary
acylglycine analysis by, 2105
Quadrupole mass spectrometer
effect of axial magnetic field on, 2070
resolution of low mass isotopes, 1364
Quality control
mass measurement terminology and treatment of data, 1821
peptide profiling in serum, isotopic distribution for MALDI-
TOF- and MALDI-FTICR-MS, 1515
proteins, quantitation, spectral counting error statistics, Mud-
PIT, 1534
repeatability of SIFT-MS for exhaled volatile metabolites, 1070
Quantification by total identified peptides, distribution of AAs
in SILAC experiments, 1417
Rapid manufacturing technology, linear ion traps fabricated us-
ing, 317
Real-time monitoring, handheld mass spectrometer, trace air
analyses, APCI, 132
Rectilinear ion trap mass spectrometry, DMS, evaluation of,
1477
Retina, mouse, fatty acid distribution in sections of, IMS with
silver nanoparticles, 1446
Retinoic acid binding protein II, cellular, surface mapping, CID-
MS/MS, 1339
Retinoic acid receptors, nuclear, complexes with nucleic acids,
MALDI-MS, 635
Rice-Ramsperger-Kassel-Sarcus modeling, CID in tandem MS,
425
RNA
deproteinated, base loss and internal fragmentation, CID, 278
sequencing by CAD and EDD, top-down MS, 918
si, IRMPD of anions and cations, 580
transfer, top-down IT-CID-MS, 890
Sacchromyces cerevisiae, protein composition analyzed using
MALDI-LTQ-Orbitrap, 34
Saliva
human, peptide P-C analyzed by high resolution top-down
FT-MS, 868
human cystatins, mass tag assignment, top-down FT-ICR-MS,
908
SALVI-MS. see Surface-assisted laser desorptioin/ionization
mass spectrometry
Sarcosine, L-alanine and, separation from urine, ESI and IMS-
(DMA)-MS, 1129
SARMs. see Selective androgen receptor modulators
SAW-ESI-MS. see Surface acoustic wave bioaffinity electrospray
ionization mass spectroscopy
Scan waves, enhancing spectral data on tandem quadrupole MS,
1061
Secondary ion mass spectrometry
nanotome cluster bombardment after sample preparation for
imaging by, 833
relationships between cluster secondary ion intensities, 370
signal enhancement by water vapor, 2005
Selected ion flow tube mass spectrometry, repeatability of, ex-
haled volatile metabolites, 1070
Selective androgen receptor modulators, analysis by GC-micro-
chip APPI-MS, 310
Serum, metabolomic fingerprinting, optimization of DART-TOF-
MS, 68
SILAC. see Stable incorporation of labelled amino acids in cul-
ture
Silicon layers, nano-porous, adsorption of methylene blue and
papain, TOF-SIMS, 254
Sinapinic acid, thiol ester-linked, proteins containing, MALDI-
TOF-TOF-MS, 819
Site-directed mutagenesis, oxidative labeling and, bacteriorho-
dopsin, MS, 1947
Small molecules
DHB-modified nanoparticles, matrix for analysis of, MALDI-
TOF-MS, 1930
effect of ZnO nanowire length on, SALDI, 989
novel strategy for analysis of, MALDI-TOF-MS, 154
Solvents
evolution of polarity in plume, ESI-MS, 378
non-aqueous spray solvents in DESI, 572
Space charge effect, calibration function, Orbitrap FT-MS, 1846
Spectra
electronic, C6H
 and C6H3 in gas phase, 694
scan waves enhancing spectral data on tandem quadrupole
MS, 1061
Spinal cord, rat, lipids from, DESI MS imaging, 1177
Stable incorporation of labelled amino acids in culture, AA dis-
tribution in experiments, QTIPS, 1417
Stainless steel plates, characterization of unknown compounds,
MALDI-MS, 2000
Stored waveform inverse Fourier transform technology, mass
selectivity for top-down proteomics using, 455
Structural biology, limitations in native MS, 971
Sugars, isomers of, analysis using the kinetic method, 60
Sulfur, calibration standard for LDI-MS, 112
Supercharging, reagents for, proteins, ESI-MS, 127
Supercharging reagents, and myoglobin conformation, ESI, 1762
Surface acoustic wave bioaffinity electrospray ionization mass
spectroscopy, quantification of protein-ligand interactions,
1643
Surface-assisted laser desorptioin/ionization mass spectrometry,
effects of ZnO nanowire length on small molecules, 989
Surface-assisted laser desorption/ionization mass spectrometry
peptides and proteins, 1204
quantification of captropril in urine using, 864
Surfactant sprays, enhanced ion signals via, DESI, 1423
SWIFT. see Stored waveform inverse Fourier transform technol-
ogy
Tandem mass spectrometry
analysis of isomeric sugars using kinetic methods, 60
dinucleotides, identification of fragmentation channels using
deuterium labeling, 23
enkephalin and leucine dissociation kinetics, time resolved
photodissociation MALDI-TOF-MS/MS, 1151
fusaric acid as derivatizing reagent for hydroxy steroid quan-
tification, LC-ESI-MS/MS, 249
MAZIE enhances database searching of MS/MS spectra, 80
N-terminal tagging of peptides for denovo sequencing, ESI-
MS/MS and MALDI-MS/MS, 104
peptide sequence scrambling via macrocyclic b ions, 2085
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peptide sequencing on single resin beads, MALDI-FTICR-MS/
MS, 215
phosphopeptide enrichment by MOAC resins, MS/MS, 1649
quadrupole, scan waves enhancing spectral data on, 1061
Rice-Ramsperger-Kassel-Sarcus modeling in CID, 425
TCEP cleavage of cysteine-containing proteins, LC/MS/MS,
837
top-down high resolution, swine cardiac troponin, 940
Yersinia pestis lipid A phosphorylation configuration, 785
Targeted ion parking, biotherapeutic protein quantitation by,
2011
TCEP. see Tris (2-carboxyethyl) phosphine
Thrombin, DNA aptamer binding, alkali metal ion binding, 1245
Thymidylate synthase, inhibitor analogues, rearrangement in
ESI-MS/MS, 403
Thyroid hormones, quantification of T3 and rT3 by single ratio
kinetic method, ESI-MS, 14
Time of flight secondary ion mass spectrometry
DBDE residue localization by, rat ovaries and adrenal glands,
1836
nano-porous silicon layer adsorption of methylene blue and
papain, 254
Tissue samples
brain, glycosphingolipids, use of gold nanoparticles and IMS,
1940
nanotome cluster bombardment after sample preparation for
imaging by SIMS, 833
protein identification and imaging, MALDI-IMS, 338
proteins, imaging and profiling, MALDI-MS, 1922
TOF SIMS. see Time of flight secondary ion mass spectrometry
Toluene
handheld mass spectrometer, trace air analyses, APCI, 132
petroleum in, APCI analysis, 386
Trajectories modeling, CID in tandem MS, 425
Traveling wave ion mobility mass spectrometry
chemically cross-linked peptides, 2062
prion protein analyzed by DCIM-MS and, 845
Triacylglycerols, analysis by ESI-LIT-MS, 657
Tris (2-carboxyethyl) phosphine, cleavage of cysteine-containing
proteins, LC/MS/MS, 837
Troponin I, swine cardiac, top-down high-resolution MS/MS,
940
Trypsin, microwave-assisted and conventional-catalyzed reac-
tions, 421
Tryptophan, oxidation of residues, MS, 1114
Tyrosylprotein sulfotransferase-2, catalytic mechanism analyzed
by MS, 1633
UASI MS. see Ultrasonication-assisted spray ionization mass
spectrometry
Ubiquitin, N-terminal platination by cisplatin, ion mobility MS,
1097
Ultra-performance liquid chromatography, urinary acylglycine
analysis by UPLC-QLTC-MS, 2105
Ultrasonication-assisted spray ionization mass spectrometry, bi-
omolecule analysis by, 1547
Uranium, UO4- formed during CID, 1789
Uranyl carboxylates, variable denticity in coordination com-
plexes, IRMPD, 719
Urine
acylglycine analysis by UPLC-QLTC-MS, 2105
captopril quantification using SALVI-MS, 864
L-alanine and sarcosine separation from, ESI and IMS(DMA)-
MS, 1129
VOC, formula confirmation by high resolution PTR-TOF, 1037
Yeast, protein composition analyzed using MALDI-LTQ-
Orbitrap, 34
Yersinia pestis, lipid A phosphorylation configuration, MS/MS,
785
z ions, dissociations of, non-tryptic peptides, 1279
Zinc oxide, MS study of impurity profile, 1620
Zinc oxide nanowire, effect of nanowire length on small mole-
cules, SALDI, 989
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